An investment in our common stock involves risks. Before making an investment decision, you should carefully consider all the information within Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as in our condensed consolidated financial statements and the related notes contained in Part I, Item 1 within this Quarterly Report. In addition, you should carefully consider the risks and uncertainties described in Part I, Item 1A, “Risk Factors,” of our 2026 Annual Report, as well as in our other public filings with the SEC. If any of the identified risks are realized, our business, results of operations, financial condition, liquidity, and prospects could be materially and adversely affected. In that case, the trading price of our common stock may decline, and you could lose all or part of your investment. In addition, other risks of which we are currently unaware, or which we do not currently view to be material, could have a material adverse effect on our business, results of operations, financial condition, liquidity, and prospects. During the three months ended June 30, 2026, there were no material changes to the risks and uncertainties described in Part I, Item 1A, “Risk Factors,” of our 2026 Annual Report. Table of Contents 31 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Unregistered Sales of Equity Securities None. Use of Proceeds Not applicable. Purchases of Equity Securities by the Issuer and Affiliated Purchasers Our Board of Directors (Board) has approved a stock repurchase program which authorizes us to repurchase shares of our common stock in the open market or in privately negotiated transactions, subject to market conditions, applicable legal requirements, and other factors (collectively, the stock repurchase program). Our Board last approved an additional authorization of $3,500,000 on May 20, 2026, to repurchase shares of our common stock under the same conditions as our prior stock repurchase program. As of June 30, 2026, the aggregate remaining authorization under our stock repurchase program is $4,711,416. Our stock repurchase program does not obligate us to acquire any amount of common stock and may be suspended at any time at our discretion. Stock repurchase activity under our stock repurchase program during the three months ended June 30, 2026, was as follows: Total Number of Shares Repurchased (1) (2) Weighted Average Price per Share Dollar Value of Shares Repurchased (2) (3) Dollar Value of Shares Remaining for Repurchase (2) April 1 - April 30, 2026 1,047,701 $105.95 $110,999 $1,438,603 May 1 - May 31, 2026 1,317,560 99.57 131,188 4,807,415 June 1 - June 30, 2026 893,091 107.49 95,999 4,711,416 Total 3,258,352 103.79 $338,186 4,711,416 (1) All share repurchases were made pursuant to our stock repurchase program in open-market transactions. (2) May not calculate on rounded amounts. (3) The dollar value of shares repurchased excludes the cost of broker commissions, excise taxes, and other costs. Subsequent to June 30, 2026, through July 9, 2026, we repurchased 311,264 shares of our common stock at a weighted average price of $103.35 per share for $32,168. As of July 9, 2026, we had $4,679,248 remaining authorized for repurchases under the stock repurchase program. Refer to the section titled “Liquidity” under Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 8, “Stockholders’ Equity,” of our condensed consolidated financial statements in Part I, Item 1 within this Quarterly Report, for further information on our stock repurchase program. Table of Contents 32